O6 Methylguanine Dna Methyltransferase (mgmt) - Histology

Relevant Publications

No benefit from TMZ treatment in GB with truly unmethylated MGMT promoter: Reanalysis of the CE.6 and the pooled Nordic/NOA-08 trials in elderly GB patients.

Issue Release: 2024

Epigenetic modification and characterization of the promoter region using CRISPRoff in glioblastoma cells.

Issue Release: 2024

Predominance of MGMT promoter methylation among Pakistani glioblastoma patients.

Issue Release: 2024

AI-driven estimation of O6 methylguanine-DNA-methyltransferase (MGMT) promoter methylation in glioblastoma patients: a systematic review with bias analysis.

Issue Release: 2024

A novel approach to investigate the combinatorial effects of TLK1 (Tousled-Like Kinase1) inhibitors with Temozolomide for glioblastoma therapy.

Issue Release: 2024

Preoperative prediction of MGMT promoter methylation in glioblastoma based on multiregional and multi-sequence MRI radiomics analysis.

Issue Release: 2024

Glioma Grade and Molecular Markers: Comparing Machine-Learning Approaches Using VASARI (Visually AcceSAble Rembrandt Images) Radiological Assessment.

Issue Release: 2024

Quality assessment of the MRI-radiomics studies for MGMT promoter methylation prediction in glioma: a systematic review and meta-analysis.

Issue Release: 2024

Sex-specific Differences in IDH1-Wildtype Glioblastoma patients in the ReSPOND Consortium.

Issue Release: 2024

Nanoliposomes a future based delivery vehicle of cyanidin-3-O-glucoside against major chronic disease.

Issue Release: 2024

Accidental Encounter of Repair Intermediates in Alkylated DNA May Lead to Double-Strand Breaks in Resting Cells.

Issue Release: 2024

Albumin-Based Microneedles for Spatiotemporal Delivery of Temozolomide and Niclosamide to Resistant Glioblastoma.

Issue Release: 2024

MEN1 Deficiency-Driven Activation of the β-Catenin-MGMT Axis Promotes Pancreatic Neuroendocrine Tumor Growth and Confers Temozolomide Resistance.

Issue Release: 2024

Evaluation of the clinical use of MGMT methylation in extracellular vesicle-based liquid biopsy as a tool for glioblastoma patient management.

Issue Release: 2024

Selective regulation of chemosensitivity in glioblastoma by phosphatidylinositol 3-kinase beta.

Issue Release: 2024

Imaging Role in Diagnosis, Prognosis, and Treatment Response Prediction Associated with High-grade Glioma.

Issue Release: 2024

AB003. Clinical analysis of central nervous system (CNS) World Health Organization (WHO) grade 4 gliomas with IDH-mutant versus IDH-wildtype focused on CDKN2A homozygous deletion.

Issue Release: 2024

AB071. Predictive value of plasma microRNA-10b and microRNA-21 on chemotherapy toxicity, recurrence, and overall survival in high-grade glioma patients treated with temozolomide.

Issue Release: 2024

MGMT ProFWise: Unlocking a New Application for Combined Feature Selection and the Rank-Based Weighting Method to Link MGMT Methylation Status to Serum Protein Expression in Patients with Glioblastoma.

Issue Release: 2024

Stratification of glioma based on stemness scores in bulk and single-cell transcriptomes.

Issue Release: 2024

What are the Phases of Tissue Repair?

Why Are e-Learning Modules Important in Histology?

What are Myeloproliferative Disorders?

How Are Micrographs Prepared?

How do antifungals contribute to histological studies?

What is Understaining in Histology?

What are some cutting-edge techniques in Histology?

What Are the Implications of Dysregulation?

How is SASP Identified in Histology?

What is the Importance of Epithelial Tissue in Anatomical Architecture?

O6 Methylguanine Dna Methyltransferase (mgmt) - Histology

Relevant Publications

Partnered Content Networks

Relevant Topics